Volume 4, Issue 3 (2018)
IEM 2018, 4(3): 93-98 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rezaie N, Pourshafie M. Increased Resistance to Tetracycline and Erythromycin in Vibrio Cholerae Clinical Isolates Isolated from Patients with Cholera Disease during 2012-2013 Outbreaks in IR Iran. IEM 2018; 4 (3) :93-98
URL: http://iem.modares.ac.ir/article-4-26124-en.html
URL: http://iem.modares.ac.ir/article-4-26124-en.html
1- Microbiology Department, Pasteur Institute of Iran, Tehran, Iran
2- Microbiology Department, Pasteur Institute of Iran, Tehran, Iran , m_pour@pasteur.ac.ir
2- Microbiology Department, Pasteur Institute of Iran, Tehran, Iran , m_pour@pasteur.ac.ir
Abstract: (4604 Views)
Aims: Vibrio cholerae is one of the intestinal gram-negative bacteria, causing cholera disease in developing countries; the two serogroups of O1 and O139 are the main causes of diarrhea. The bacteria resistance pattern to antibiotics varies in different countries. The aim of this study was to determine the resistance pattern of the isolates to representative antibiotics.
Materials & Methods: A total of 20 V. cholerae clinical strains were isolated from patients with cholera in Sistan and Baluchestan province of Iran during 2012-2013 outbreaks. After being identified by biochemical and molecular techniques, antibiotic susceptibility testing was performed for 6 antibiotics according to CLSI standards. Then, minimum inhibitory concentration (MIC) was also determined for tetracycline and erythromycin, using E-Test method.
Findings: All of the isolates were EL Tor biotype, O1 serogroup, and Inaba serotype. All of isolates were resistant to erythromycin and nalidixic acid, and 50% were resistant to tetracycline, while no resistance was observed against to ciprofloxacin, gentamicin, and ampicillin.
Conclusion: The sensitivity of all clinical isolates to antibiotics mentioned suggests that these antibiotics can likely be used in cholera disease treatment.
Article Type: Original Research |
Subject:
Bacteriology
Received: 2018/04/14 | Accepted: 2018/07/17 | Published: 2018/09/22
Received: 2018/04/14 | Accepted: 2018/07/17 | Published: 2018/09/22
References
1. Coppo A, Colombo M, Pazzani C, Bruni R, Mohamud KA, Omar KH, et al. Vibrio cholerae in the horn of Africa: Epidemiology, plasmids, tetracycline resistance gene amplification, and comparison between O1 and non-O1 strains. Am J Trop Med Hyg. 1995;53(4):351-9. [Link] [DOI:10.4269/ajtmh.1995.53.351]
2. Waldor MK, Mekalanos JJ. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science. 1996;272(5270):1910-4. [Link] [DOI:10.1126/science.272.5270.1910]
3. Mekalanos JJ. Duplication and amplification of toxin genes in Vibrio cholerae. Cell. 1983;35(1):253-63. [Link] [DOI:10.1016/0092-8674(83)90228-3]
4. Pearson GD, Woods A, Chiang SL, Mekalanos JJ. CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. Proc Natl Acad Sci USA. 1993;90(8):3750-4. [Link] [DOI:10.1073/pnas.90.8.3750]
5. Zalunardo N, Lemaire M, Davids MR, Halperin ML. Acidosis in a patient with cholera: A need to redefine concepts. Q J Med. 2004;97(10):681-96. [Link] [DOI:10.1093/qjmed/hch110]
6. Rahbar M, Sabourian R, Saremi M, Abbasi M, Masoumi Asl H, Soroush M. Epidemioloic and drug resistant pattern of Vibrio cholerae O1 biotype EL Tor, serotype Inaba during the summer of 2005 outbreak in Iran. J Ardabil Univ Med Sci. 2007;1(7):41-5. [Persian] [Link]
7. Niknezhad F, Kabir MJ, Keshtkar A, Hazrati B, Kurdjazi N, Rezayyan I, et al. Antibiotic sensitivity of the Vibrio cholera isolated from rectal swab of Golestan′ patients. Medical Lab J. 2007;1(2):32-6. [Persian] [Link]
8. Choopun N, Louis V, Huq A, Colwell RR. Simple procedure for rapid identification of Vibrio cholerae from the aquatic environment. Appl Environ Microbiol. 2002;68(2):995-8. [Link] [DOI:10.1128/AEM.68.2.995-998.2002]
9. Chun J, Huq A, Colwell RR. Analysis of 16S-23S rRNA intergenic spacer regions of Vibrio cholerae and Vibrio mimicus. Appl Environ Microbiol. 1999;65(5):2202-8. [Link]
10. Feeley JC. Classification of Vibrio cholerae (Vibrio comma), including El Tor vibrios, by infrasubspecific characteristics. J Bacteriol. 1965;89:665-70. [Link]
11. Perilla MJ, Ajello G, Bopp Ch, Elliott J, Facklam R, Knapp JS, et al. Manual for the laboratory identification and antimicrobial susceptibility testing of bacterial pathogens of public health importance in the developing world: Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, Neisseria gonorrhoeae, Salmonella serotype Typhi, Shigella, and Vibrio cholera [Internet]. Geneva: World Health Organization; 2003 [2 Jul 2003]. Available from: http://apps.who.int/iris/handle/10665/68554 [Link]
12. Clinical and Laboratory Standards Institute. M45-A2: Methods for antimicrobial dilution and disc susceptibility testing of infrequently isolated or fastidious bacteria; Approved guideline. 2nd Edition. Wayne: Clinical and Laboratory Standards Institute; 2010. [Link]
13. Afzali H, Momen-Heravi M, Razzaghi R. Antibiotic resistance of Vibrio cholerae isolates from Kashan, Iran. Q Int Arch Health Sci. 2016;3(2):67-71. [Link] [DOI:10.18869/IAHS.3.2.67]
14. Keramat F, Hashemi Sh, Mamani M, Ranjbar M, Erfani H. Survey of antibiogram tests in cholera patients in the 2005 epidemic in Hamadan, Islamic Republic of Iran. East Mediterr Health J. 2008;14(4)768-75. [Link]
15. Pourshafie MR, Sedaghat M, Rahimi F, Talebi M. Serotyping, antibiotic susceptibility pattern and detection of hlyA gene among Cholera patients in Iran. Jundishapur J Microbiol. 2013;6(1):20-3. [Link]
16. Rahbar Taramsari M, Khosh Amooz H, Hoseini S, Badsar AR, Vanak Araghiyan A, Falah Karkan M. Antibiotic resistance pattern of Cholera epidemy in Guilan province. J Guilan Univ Med Sci. 2012;21(82):24-30. [Persian] [Link]
17. Tabatabaei SM, Salimi Khorashad A. Antimicrobial resistance patterns of Vibrio cholera strains isolated from Afghan and Iranian patients in Iran. Int J Infect. 2015;2(1):e22822. [Link] [DOI:10.17795/iji-22822]
18. Sheikh A, Khan A, Malik T, Fisher-Hoch SP. Cholera in a developing megacity; Karachi, Pakistan. Epidemiol Infec. 1997;119(3):287-92. [Link] [DOI:10.1017/S0950268897008212]
19. Klontz EH, Das SK, Ahmed D, Ahmed Sh, Chisti MJ, Malek MA, et al. Long-term comparison of antibiotic resistance in Vibrio cholerae O1 and Shigella species between urban and rural Bangladesh. Clin Infect Dis. 2014;58(9):e133-6. [Link] [DOI:10.1093/cid/ciu040]
20. Dengo-Baloi LC, Semá-Baltazar CA, Manhique LV, Chitio JE, Inguane DL, Langa JP. Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015. PloS one. 2017;12(8):e0181496. [Link] [DOI:10.1371/journal.pone.0181496]
21. Bakhshi B, Pourshafie MR, Navabakbar F, Tavakoli A, Shahcheraghi F, Salehi M, et al. Comparison of distribution of virulence determinants in clinical and environmental isolates of Vibrio cholera. Iran Biomed J. 2008;12(3):159-65. [Link]
22. Pourshafie MR, Bakhshi B, Ranjbar R, Sedaghat M, Sadeghifard N, Zaemi Yazdi J, et al. Dissemination of a single Vibrio cholerae clone in cholera outbreaks during 2005 in Iran. J Med Microbiol. 2007;56(Pt 12):1615-9. [Link] [DOI:10.1099/jmm.0.47218-0]
23. Masoumi-Asl H, Gouya MM, Rahbar M, Sabourian R. The epidemiology and antimicrobial resistance of cholera cases in Iran during 2013. Iran J Microbiol. 2016;8(4):232-7. [Link]
24. Hajia M, Rahbar M, Farzami MR, Asl HM, Dolatyar A, Imani M, et al. Assessing clonal correlation of epidemic Vibrio cholerae isolates during 2011 in 16 provinces of Iran. Curr Microbiol. 2015;70(3):408-14. [Link] [DOI:10.1007/s00284-014-0725-2]
25. Ang GY, Yu CY, Balqis K, Elina HT, Azura H, Hani MH, et al. Molecular evidence of cholera outbreak caused by a toxigenic Vibrio cholerae O1 El Tor variant strain in Kelantan, Malaysia. J Clin Microbiol. 2010;48(11):3963-9. [Link] [DOI:10.1128/JCM.01086-10]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |